Safety of Gadoterate Meglumine (Gd-DOTA) as a Contrast Agent for Magnetic Resonance Imaging: Results of a Post-Marketing Surveillance Study in Japan

Author: Ishiguchi Tsuneo  

Publisher: Adis International

ISSN: 1174-5886

Source: Drugs in R&D, Vol.10, Iss.3, 2010-09, pp. : 133-145

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content